<VariationArchive RecordType="classified" VariationID="1343402" VariationName="NM_006031.6(PCNT):c.5059_5060del (p.Asn1687fs)" VariationType="Deletion" Accession="VCV001343402" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-03-12" MostRecentSubmission="2022-03-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1335102" VariationID="1343402">
      <GeneList>
        <Gene Symbol="PCNT" FullName="pericentrin" GeneID="5116" HGNC_ID="HGNC:16068" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46324156" stop="46445769" display_start="46324156" display_stop="46445769" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47744035" stop="47865681" display_start="47744035" display_stop="47865681" Strand="+" />
          </Location>
          <OMIM>605925</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006031.6(PCNT):c.5059_5060del (p.Asn1687fs)</Name>
      <CanonicalSPDI>NC_000021.9:46402426:AA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46402427" stop="46402428" display_start="46402427" display_stop="46402428" variantLength="2" positionVCF="46402426" referenceAlleleVCF="GAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47822341" stop="47822342" display_start="47822341" display_stop="47822342" variantLength="2" positionVCF="47822340" referenceAlleleVCF="GAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N1569fs</ProteinChange>
      <ProteinChange>N1687fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.47822341_47822342del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.47822341_47822342del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.46402427_46402428del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.46402427_46402428del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008961.2" sequenceAccession="NG_008961" sequenceVersion="2" change="g.83306_83307del">
            <Expression>NG_008961.2:g.83306_83307del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001315529.2" sequenceAccession="NM_001315529" sequenceVersion="2" change="c.4705_4706del">
            <Expression>NM_001315529.2:c.4705_4706del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001302458.1" sequenceAccession="NP_001302458" sequenceVersion="1" change="p.Asn1569fs">
            <Expression>NP_001302458.1:p.Asn1569fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006031.6" sequenceAccession="NM_006031" sequenceVersion="6" change="c.5059_5060del" MANESelect="true">
            <Expression>NM_006031.6:c.5059_5060del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006022.3" sequenceAccession="NP_006022" sequenceVersion="3" change="p.Asn1687fs">
            <Expression>NP_006022.3:p.Asn1687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2147504920" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006031.6(PCNT):c.5059_5060del (p.Asn1687fs) AND Microcephalic osteodysplastic primordial dwarfism type II" Accession="RCV001844423" Version="2">
        <ClassifiedConditionList TraitSetID="1291">
          <ClassifiedCondition DB="MedGen" ID="C0432246">Microcephalic osteodysplastic primordial dwarfism type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-02-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-12" MostRecentSubmission="2022-03-12">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18174396</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1291" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2931" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Microcephalic osteodysplastic primordial dwarfism with tooth abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microcephalic osteodysplastic primordial dwarfism type 2</ElementValue>
                <XRef ID="Microcephalic+osteodysplastic+primordial+dwarfism+type+2/4731" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MOPD II</ElementValue>
                <XRef Type="MIM" ID="210720" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II</ElementValue>
                <XRef Type="MIM" ID="210720" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MOPD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteodysplastic primordial dwarfism type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Microcephalic osteodysplastic primordial dwarfism type II</ElementValue>
                <XRef ID="301116" DB="GeneTests" />
                <XRef ID="MONDO:0008872" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MOPD2</ElementValue>
                <XRef Type="MIM" ID="210720" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Microcephalic osteodysplastic primordial dwarfism type II (MOPDII), the most common form of microcephalic primordial dwarfism, is characterized by extreme short stature and microcephaly along with distinctive facial features. Associated features that differentiate it from other forms of primordial dwarfism and that may necessitate treatment include: abnormal dentition, a slender bone skeletal dysplasia with hip deformity and/or scoliosis, insulin resistance / diabetes mellitus, chronic kidney disease, cardiac malformations, and global vascular disease. The latter includes neurovascular disease such as moyamoya vasculopathy and intracranial aneurysms (which can lead to strokes), coronary artery disease (which can lead to premature myocardial infarctions), and renal vascular disease. Hypertension, which is also common, can have multiple underlying causes given the complex comorbidities.</Attribute>
                <XRef ID="NBK575926" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9844" />
                <XRef ID="9844" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34978779</ID>
                <ID Source="BookShelf">NBK575926</ID>
              </Citation>
              <XRef ID="2637" DB="Orphanet" />
              <XRef ID="C0432246" DB="MedGen" />
              <XRef ID="MONDO:0008872" DB="MONDO" />
              <XRef Type="MIM" ID="210720" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4114706" SubmissionDate="2022-03-10" DateLastUpdated="2022-03-12" DateCreated="2022-03-12">
        <ClinVarSubmissionID localKey="SUB11169094" submittedAssembly="GRCh37" title="SUB11169094" />
        <ClinVarAccession Accession="SCV002103304" DateUpdated="2022-03-12" DateCreated="2022-03-12" Type="SCV" Version="1" SubmitterName="Human Genetics Unit, University Of Colombo" OrgID="505980" OrganizationCategory="laboratory" OrgAbbreviation="HGU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">18174396</ID>
          </Citation>
          <Comment>The variant, denoted as c.5059_5060delAA at cDNA level, is located in exon 27 of the PCNT gene. At protein level, it substitutes the Glutamine resulting a premature Stop codon at position 11 of the new reading frame. This frameshift predicted to cause non-sense mediated decay of mRNA leading to loss of PCNT protein. Bi-allelic loss of function in PCNT gene is a known mechanism of the disease MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II(PMID:18174396 ). This variant is not found in global population frequency databases or in our internal exome database and found in trans with a pathogenic variant in an affected individual. Hence this variant is classified as a pathogenic variant according to the following ACMG guidelines. PVS1, PM2, PM3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Sinhalese</Ethnicity>
              <GeographicOrigin>Sri Lanka</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCNT">
              <Name>pericentrin</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006031.5:exon 27</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006031.5:c.5059_5060delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="210720" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11169094</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4114706" TraitType="Disease" MappingType="XRef" MappingValue="210720" MappingRef="OMIM">
        <MedGen CUI="C0432246" Name="Microcephalic osteodysplastic primordial dwarfism type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

